{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:17:08Z","timestamp":1790864228125,"version":"4.1.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,1,29]],"date-time":"2011-01-29T00:00:00Z","timestamp":1296259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s11154-011-9156-6","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T17:24:44Z","timestamp":1296235484000},"page":"3-9","source":"Crossref","is-referenced-by-count":24,"title":["Diagnosis and treatment of primary aldosteronism"],"prefix":"10.1007","volume":"12","author":[{"given":"Paolo","family":"Mulatero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Monticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Veglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,29]]},"reference":[{"key":"9156_CR1","first-page":"6","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn JW. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45:6\u201317.","journal-title":"J Lab Clin Med"},{"key":"9156_CR2","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199812173392507","volume":"339","author":"A Ganguly","year":"1998","unstructured":"Ganguly A. Primary aldosteronism. N Engl J Med. 1998;339:1828\u201334.","journal-title":"N Engl J Med"},{"key":"9156_CR3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"9156_CR4","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis and treatment of patients with primary aldosteronism: an endocrine society clinical practice guidelines. J Clin Endocrinol Metab. 2008;93:3266\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"9156_CR5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0895-7061(03)00858-6","volume":"16","author":"S Abdelhamid","year":"2003","unstructured":"Abdelhamid S, Blomer R, Hommel G, et al. Urinary tetrahydroaldosterone as a screening method for primary aldosteronism: a comparative study. Am J Hypertens. 2003;16:522\u201330.","journal-title":"Am J Hypertens"},{"key":"9156_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","volume":"42","author":"L Mosso","year":"2003","unstructured":"Mosso L, Carvajal C, Gonz\u00e1lez A, et al. Primary aldosteronism and hypertensive disease. Hypertension. 2003;42:161\u20135.","journal-title":"Hypertension"},{"key":"9156_CR7","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, et al. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40:892\u20136.","journal-title":"Hypertension"},{"key":"9156_CR8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/157340205774574595","volume":"1","author":"P Mulatero","year":"2005","unstructured":"Mulatero P, Milan A, Rabbia F, et al. Diagnosis of surgically treatable forms of primary aldosteronism. Curr Hypert Rev. 2005;1:259\u201366.","journal-title":"Curr Hypert Rev"},{"key":"9156_CR9","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1210\/en.2006-1509","volume":"148","author":"DG Romero","year":"2007","unstructured":"Romero DG, Yanes LL, de Rodriguez AF, et al. Disabled-2 is expressed in adrenal zona glomerulosa and is involved in aldosterone secretion. Endocrinology. 2007;148:2644\u201352.","journal-title":"Endocrinology"},{"key":"9156_CR10","doi-asserted-by":"crossref","unstructured":"Gomez-Sanchez CE, Rossi GP, Fallo F, Mannelli M. Progress in primary aldosteronism: present challenges and perspectives. Horm Metab Res. 2010. In Press.","DOI":"10.1055\/s-0029-1243619"},{"key":"9156_CR11","doi-asserted-by":"crossref","first-page":"6638","DOI":"10.1210\/jc.2005-1309","volume":"90","author":"G Assi\u00e9","year":"2005","unstructured":"Assi\u00e9 G, Auzan C, Gasc JM, et al. Steroidogenesis in aldosterone-producing adenoma revisited by transcriptome analysis. J Clin Endocrinol Metab. 2005;90:6638\u201349.","journal-title":"J Clin Endocrinol Metab"},{"key":"9156_CR12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1530\/eje.1.02051","volume":"153","author":"D Cartier","year":"2005","unstructured":"Cartier D, J\u00e8gou S, Parmentier F, et al. Expression profile of serotonin 4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas. Eur J Endocrinol. 2005;153:939\u201347.","journal-title":"Eur J Endocrinol"},{"key":"9156_CR13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/HYPERTENSIONAHA.107.100438","volume":"50","author":"L Lenzini","year":"2007","unstructured":"Lenzini L, Seccia TM, Aldighieri E, et al. Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension. 2007;50:1106\u201313.","journal-title":"Hypertension"},{"key":"9156_CR14","doi-asserted-by":"crossref","unstructured":"Williams TA, Monticone S, Morello F et al. TDGF-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Hypertension. 2010; In Press.","DOI":"10.1161\/HYPERTENSIONAHA.110.150318"},{"key":"9156_CR15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"9156_CR16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/187152506775268776","volume":"4","author":"P Mulatero","year":"2006","unstructured":"Mulatero P, Milan A, Williams TA, Veglio F. Mineralocorticoid receptor blockade in the protection of target organ damage. Cardiovasc Hematol Agents Med Chem. 2006;4:75\u201391.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"9156_CR17","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1210\/jc.2003-032179","volume":"89","author":"O Olivieri","year":"2004","unstructured":"Olivieri O, Ciacciarelli A, Signorelli D, et al. Aldosterone to renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab. 2004;89:4221\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"9156_CR18","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1373\/clinchem.2004.033654","volume":"50","author":"D Hartman","year":"2004","unstructured":"Hartman D, Sagnella GA, Chester CA, MacGragor GA. Direct renin assay and plasma rennin activity assay compared. Clin Chem. 2004;50:2159\u201361.","journal-title":"Clin Chem"},{"key":"9156_CR19","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1373\/clinchem.2005.061184","volume":"52","author":"F Pizzolo","year":"2006","unstructured":"Pizzolo F, Corgnati A, Guarini P, et al. Plasma aldosterone assays: comparison between chemiluminescence-based and RIA methods. Clin Chem. 2006;52:1431\u20132.","journal-title":"Clin Chem"},{"key":"9156_CR20","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1373\/clinchem.2006.073460","volume":"52","author":"M Stowasser","year":"2006","unstructured":"Stowasser M, Gordon RD. Aldosterone assays: an urgent need for improvement. Clin Chem. 2006;52:1640\u20132.","journal-title":"Clin Chem"},{"key":"9156_CR21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1521-690X(03)00050-2","volume":"17","author":"M Stowasser","year":"2003","unstructured":"Stowasser M, Gordon RD. Primary aldosteronism. Best Pract Res Clin Endocrinol Metab. 2003;17:591\u2013605.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9156_CR22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3317\/jraas.2001.022","volume":"2","author":"M Stowasser","year":"2001","unstructured":"Stowasser M, Gordon RD, Rutheford JC, et al. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2001;2:156\u201369.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"9156_CR23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/01.HYP.0000038478.59760.41","volume":"40","author":"P Mulatero","year":"2002","unstructured":"Mulatero P, Rabbia F, Milan A, et al. Drug effects on aldosterone\/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002;40:897\u2013902.","journal-title":"Hypertension"},{"key":"9156_CR24","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","volume":"144","author":"WF Young Jr","year":"2003","unstructured":"Young Jr WF. Minireview: primary aldosteronism\u2013changing concepts in diagnosis and treatment. Endocrinology. 2003;144:2208\u201313.","journal-title":"Endocrinology"},{"key":"9156_CR25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/eje.0.1500329","volume":"150","author":"L Seiler","year":"2004","unstructured":"Seiler L, Rump LC, Schulte-M\u00f6nting J, et al. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. Eur J Endocrinol. 2004;150:329\u201337.","journal-title":"Eur J Endocrinol"},{"key":"9156_CR26","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1210\/jc.2007-2055","volume":"93","author":"P Mulatero","year":"2008","unstructured":"Mulatero P, Bertello C, Rossato D, et al. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab. 2008;93:1366\u201371.","journal-title":"J Clin Endocrinol Metab"},{"key":"9156_CR27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ajh.2009.63","volume":"22","author":"BM Egan","year":"2009","unstructured":"Egan BM, Basile JN, Rehman SU, et al. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009;22:792\u2013801.","journal-title":"Am J Hypertens"},{"key":"9156_CR28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/0151642-200815030-00005","volume":"15","author":"A Verhovez","year":"2008","unstructured":"Verhovez A, Mulatero P, Bertello C, et al. Is renin-based treatment a reasonable strategy to treat essential hypertension? High Blood Press Cardiovasc Prev. 2008;15:121\u20135.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"9156_CR29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1001\/archsurg.1996.01430180072015","volume":"131","author":"O Celen","year":"1996","unstructured":"Celen O, O\u2019Brien MJ, Melby JC, Beazley RM. Factors influencing out-come of surgery for primary aldosteronism. Arch Surg. 1996;131:646\u201350.","journal-title":"Arch Surg"},{"key":"9156_CR30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/ajh\/3.5.360","volume":"3","author":"DH Streeten","year":"1990","unstructured":"Streeten DH, Anderson Jr GH, Wagner S. Effect of age on response of secondary hypertension to specific treatment. Am J Hypertens. 1990;3:360\u20135.","journal-title":"Am J Hypertens"},{"key":"9156_CR31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","volume":"168","author":"C Catena","year":"2008","unstructured":"Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008;168:80\u20135.","journal-title":"Arch Intern Med"},{"key":"9156_CR32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.jhh.1001948","volume":"20","author":"JS Williams","year":"2006","unstructured":"Williams JS, Williams GH, Raji A, et al. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens. 2006;20:129\u201336.","journal-title":"J Hum Hypertens"},{"key":"9156_CR33","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.02898.x","volume":"67","author":"P Mulatero","year":"2007","unstructured":"Mulatero P, Verhovez A, Morello F, Veglio F. Diagnosis and treatment of low-renin hypertension. Clin Endocrinol (Oxf). 2007;67:324\u201334.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9156_CR34","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1097\/HJH.0b013e3283060f0c","volume":"26","author":"E Letavernier","year":"2008","unstructured":"Letavernier E, Peyrard S, Amar L, et al. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens. 2008;26:1816\u201323.","journal-title":"J Hypertens"},{"key":"9156_CR35","doi-asserted-by":"crossref","unstructured":"Mulatero P, Monticone S, Bertello C et al. Confirmatory tests in the diagnosis of primary aldosteronism. Horm Metab Res. 2010; In Press.","DOI":"10.1055\/s-0029-1246186"},{"key":"9156_CR36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","volume":"50","author":"GP Rossi","year":"2007","unstructured":"Rossi GP, Belfiore A, Bernini G, et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension. 2007;50:424\u201331.","journal-title":"Hypertension"},{"key":"9156_CR37","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/HYPERTENSIONAHA.107.093468","volume":"50","author":"P Mulatero","year":"2007","unstructured":"Mulatero P, Bertello C, Garrone C, et al. Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension. 2007;50:e26\u20137.","journal-title":"Hypertension"},{"key":"9156_CR38","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1210\/jc.2009-1399","volume":"94","author":"M Stowasser","year":"2009","unstructured":"Stowasser M. Update in primary aldosteronism. J Clin Endocrinol Metab. 2009;94:3623\u201330.","journal-title":"J Clin Endocrinol Metab"},{"key":"9156_CR39","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1210\/jc.2006-0078","volume":"91","author":"P Mulatero","year":"2006","unstructured":"Mulatero P, Milan A, Fallo F, et al. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocrinol Metab. 2006;91:2618\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"9156_CR40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11906-009-0038-1","volume":"11","author":"P Mulatero","year":"2009","unstructured":"Mulatero P, Bertello C, Verhovez A, et al. Differential diagnosis of primary aldosteronism subtypes. Curr Hypertens Rep. 2009;11:217\u201323.","journal-title":"Curr Hypertens Rep"},{"key":"9156_CR41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11154-007-9055-z","volume":"8","author":"WF Young","year":"2007","unstructured":"Young WF. Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism. Rev Endocr Metab Disord. 2007;8:309\u201320.","journal-title":"Rev Endocr Metab Disord"},{"key":"9156_CR42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","volume":"141","author":"FE Nwariaku","year":"2006","unstructured":"Nwariaku FE, Miller BS, Auchus R, et al. Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg. 2006;141:497\u201350.","journal-title":"Arch Surg"},{"key":"9156_CR43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","volume":"66","author":"WF Young","year":"2007","unstructured":"Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol. 2007;66:607\u201318.","journal-title":"Clin Endocrinol"},{"key":"9156_CR44","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.surg.2008.07.025","volume":"144","author":"ML White","year":"2008","unstructured":"White ML, Gauger PG, Doherty GM, et al. The role of radiologic studies in the evaluation and management of primary hyperaldosteronism. Surgery. 2008;144:926\u201333.","journal-title":"Surgery"},{"key":"9156_CR45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2265.2008.03450.x","volume":"70","author":"WF Young","year":"2009","unstructured":"Young WF, Stanson AW. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol (Oxf). 2009;70:14\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9156_CR46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1148\/radiology.198.2.8596821","volume":"198","author":"JL Doppman","year":"1996","unstructured":"Doppman JL, Gill Jr JR. Hyperaldosteronism: sampling the adrenal veins. Radiology. 1996;198:309\u201312.","journal-title":"Radiology"},{"key":"9156_CR47","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.109.134759","volume":"54","author":"D Miotto","year":"2009","unstructured":"Miotto D, De Toni R, Pitter G, et al. Impact of accessory hepatic veins on adrenal vein sampling for identification of surgically curable primary aldosteronism. Hypertension. 2009;54:885\u20139.","journal-title":"Hypertension"},{"key":"9156_CR48","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jc.86.3.1083","volume":"86","author":"GP Rossi","year":"2001","unstructured":"Rossi GP, Sacchetto A, Chiesura-Corona M, et al. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab. 2001;86:1083\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"9156_CR49","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","volume":"21","author":"M Stowasser","year":"2003","unstructured":"Stowasser M, Gordon RD, Gunasekera TG, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after \u201cnon-selective\u201d screening of hypertensive patients. J Hypertens. 2003;21:2149\u201357.","journal-title":"J Hypertens"},{"key":"9156_CR50","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Young WF, Stanson AW, Thompson GB, et al. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004;136:1227\u201335.","journal-title":"Surgery"},{"key":"9156_CR51","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1373\/clinchem.2007.092080","volume":"53","author":"G Mengozzi","year":"2007","unstructured":"Mengozzi G, Rossato D, Bertello C, et al. Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin Chem. 2007;53:1968\u201371.","journal-title":"Clin Chem"},{"key":"9156_CR52","doi-asserted-by":"crossref","unstructured":"Mulatero P, Bertello C, Sukor N et al. Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension. 2010; In Press.","DOI":"10.1097\/01.hjh.0000379120.85704.4c"},{"key":"9156_CR53","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.108.128553","volume":"53","author":"TM Seccia","year":"2009","unstructured":"Seccia TM, Miotto D, De Toni R, et al. Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols. Hypertension. 2009;53:761\u20136.","journal-title":"Hypertension"},{"key":"9156_CR54","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/HJH.0b013e3282f9e66a","volume":"26","author":"GP Rossi","year":"2008","unstructured":"Rossi GP, Pitter G, Bernante P, et al. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens. 2008;26:989\u201397.","journal-title":"J Hypertens"},{"key":"9156_CR55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/EJE-09-0217","volume":"162","author":"J Ceral","year":"2010","unstructured":"Ceral J, Solar M, Krajina A, et al. Adrenal venous sampling in primary aldosteronism: a low dilution of adrenal venous blood is crucial for a correct interpretation of the results. Eur J Endocrinol. 2010;162:101\u20137.","journal-title":"Eur J Endocrinol"},{"key":"9156_CR56","unstructured":"Stewart PM, Allolio B. Adrenal vein sampling for primary aldosteronism: time for a reality check. Clin Endocrinol (Oxf). In Press."},{"key":"9156_CR57","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton RP, Dluhy RG, Powers M, et al. A chimaeric 11\u03b2-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355:262\u20135.","journal-title":"Nature"},{"key":"9156_CR58","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00004872-200404000-00001","volume":"22","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Morello F, Veglio F. Genetics of primary aldosteronism. J Hypertens. 2004;22:663\u201370.","journal-title":"J Hypertens"},{"key":"9156_CR59","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/HJH.0b013e3283028352","volume":"26","author":"N Sukor","year":"2008","unstructured":"Sukor N, Mulatero P, Gordon RD, et al. Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J Hypertens. 2008;26:1577\u201382.","journal-title":"J Hypertens"},{"key":"9156_CR60","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","volume":"37","author":"AR Lafferty","year":"2000","unstructured":"Lafferty AR, Torpy DJ, Stowasser M, et al. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet. 2000;37:831\u20135.","journal-title":"J Med Genet"},{"key":"9156_CR61","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","volume":"49","author":"C Newton-Cheh","year":"2007","unstructured":"Newton-Cheh C, Guo CY, Gona P, et al. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension. 2007;49:846\u201356.","journal-title":"Hypertension"},{"key":"9156_CR62","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","volume":"93","author":"DS Geller","year":"2008","unstructured":"Geller DS, Zhang JJ, Wisgerhof MV, et al. A novel form of human Mendelian hypertension featuring non-glucocorticoid remediable aldosteronism. J Clin Endocrinol Metab. 2008;93:3117\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"9156_CR63","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1210\/jc.2008-1241","volume":"93","author":"P Mulatero","year":"2008","unstructured":"Mulatero P. A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J Clin Endocrinol Metab. 2008;93:2972\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"9156_CR64","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","volume":"135","author":"AM Sawka","year":"2001","unstructured":"Sawka AM, Young WF, Thompson GB, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med. 2001;135:258\u201361.","journal-title":"Ann Intern Med"},{"key":"9156_CR65","doi-asserted-by":"crossref","unstructured":"Sukor N, Kogovsek C, Gordon RD, et al. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J Clin Endocrinol Metab. 2010;95:1360\u20134.","DOI":"10.1210\/jc.2009-1763"},{"key":"9156_CR66","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","volume":"94","author":"N Sukor","year":"2009","unstructured":"Sukor N, Gordon RD, Ku YK, et al. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab. 2009;94:2437\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"9156_CR67","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14656566.9.4.509","volume":"9","author":"A Karagiannis","year":"2008","unstructured":"Karagiannis A, Tziomalos K, Papageorgiou A, et al. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism. Expert Opin Pharmacother. 2008;9:509\u201315.","journal-title":"Expert Opin Pharmacother"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-011-9156-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-011-9156-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-011-9156-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T05:52:51Z","timestamp":1559973171000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-011-9156-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,29]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["9156"],"URL":"https:\/\/doi.org\/10.1007\/s11154-011-9156-6","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,29]]}}}